相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidized CaMKII causes cardiac sinus node dysfunction in mice
Paari Dominic Swaminathan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
Farzin Beygui et al.
AMERICAN HEART JOURNAL (2010)
Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy
Hui Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Anne-Catherine Pouleur et al.
CIRCULATION (2010)
Oxidative stress irritates the heart
Gordon F. Tomaselli et al.
NATURE MEDICINE (2010)
Increased matrix metalloproteinase-8 and-9 activity in patients with infarct rupture after myocardial infarction
Susanne W. M. van den Bome et al.
CARDIOVASCULAR PATHOLOGY (2009)
IL-1 beta Induces MMP-9 Expression Via a Ca2+-Dependent CaMKII/JNK/c-Jun Cascade in Rat Brain Astrocytes
Cheng-Ying Wu et al.
GLIA (2009)
Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice
Anurag Kumar Singh et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways
Jenelle M. Timmins et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
Johannes Backs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxidized Calmodulin Kinase II Regulates Conduction Following Myocardial Infarction: A Computational Analysis
Matthew D. Christensen et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation
Jeffrey R. Erickson et al.
CELL (2008)
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury
Matthias Nahrendorf et al.
CIRCULATION (2008)
Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II
William H. Thiel et al.
CIRCULATION (2008)
Aldosterone induces superoxide generation via Rac1 activation in endothelial cells
Fumiko Iwashima et al.
ENDOCRINOLOGY (2008)
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice
Yuri Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart
Che-Hong Chen et al.
SCIENCE (2008)
Effects of carvedilol early after myocardial infarction: Analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN)
Gregg C. Fonarow et al.
AMERICAN HEART JOURNAL (2007)
Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction
Carola Doerries et al.
CIRCULATION RESEARCH (2007)
Defining the cellular phenotype of ankyrin-B syndrome variants -: Human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes
Peter J. Mohler et al.
CIRCULATION (2007)
High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction
Farzin Beygui et al.
CIRCULATION (2006)
Calcific aortic valve stenosis in old hypercholesterolemic mice
Robert M. Weiss et al.
CIRCULATION (2006)
Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy
Michelle S. C. Khoo et al.
CIRCULATION (2006)
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10
Shurong Chang et al.
CELL (2006)
CaM kinase II selectively signals to histone deacetylase 4 during cardiornyocyte hypertrophy
Johannes Backs et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase
Sofian Johar et al.
FASEB JOURNAL (2006)
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Alan D. Lopez et al.
LANCET (2006)
Role of matrix metalloproteinases in delayed cortical responses after stroke
BQ Zhao et al.
NATURE MEDICINE (2006)
Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes
MK Rude et al.
HYPERTENSION (2005)
Calmodulin kinase II inhibition protects against structural heart disease
R Zhang et al.
NATURE MEDICINE (2005)
Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice
S Matsumura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart
S Nakamura et al.
CIRCULATION (2004)
Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain
MC Zimmerman et al.
CIRCULATION RESEARCH (2004)
Cardiac rupture complicating myocardial infarction
XHT Wehrens et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment
C Maack et al.
CIRCULATION (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure -: Results from the RALES neurohormonal sub-study
MF Rousseau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis
S Hiratsuka et al.
CANCER CELL (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
